Allosteric Binding of Wild-Type and E17K Mutant AKT By Resveratrol Compared to AKT Inhibitor III (MK-2206): Computational Modeling Studies

Authors

Tze-Chen Hsieh, New York Medical CollegeFollow
Dylan J. Bennett
Barbara B. Doonan
Joseph M. Wu, New York Medical CollegeFollow

DOI

10.31488/bjcr.131

Journal Title

British Journal of Cancer Research

First Page

277

Last Page

285

Document Type

Article

Publication Date

January 2019

Department

Biochemistry and Molecular Biology

Disciplines

Medicine and Health Sciences

Recommended Citation

Hsieh, T., Bennett, D., Doonan, B., & Wu, J. (2019). Allosteric Binding of Wild-Type and E17K Mutant AKT By Resveratrol Compared to AKT Inhibitor III (MK-2206): Computational Modeling Studies. British Journal of Cancer Research, 2 (3), 277-285. https://doi.org/10.31488/bjcr.131